Cell line name | GTL16R3 |
---|---|
Synonyms | GTL16 R3 |
Accession | CVCL_VS68 |
Resource Identification Initiative | To cite this cell line use: GTL16R3 (RRID:CVCL_VS68) |
Comments | Population: Japanese. Selected for resistance to: ChEBI; CHEBI:91425; 2-[4-[3-(6-quinolinylmethyl)-5-triazolo[4,5-b]pyrazinyl]-1-pyrazolyl]ethanol (PF-04217903). Omics: SNP array analysis. Omics: Transcriptome analysis. |
Sequence variations | Gene fusion SND1-BRAF (PubMed=22745804).Heterozygous for TP53 p.Arg110Cys (c.328C>T) (ClinVar=VCV000142206) (from parent cell line). |
Disease | Gastric adenocarcinoma (NCIt: C4004) Derived from metastatic site: Liver. |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_7668 (GTL-16) |
Sex of cell | Female |
Age at sampling | 62Y |
Category | Cancer cell line |
Publications | PubMed=22745804; DOI=10.1371/journal.pone.0039653 |
Cross-references | |
Gene expression databases | GEO; GSM686017
GEO; GSM686037 GEO; GSM686038 |
Other | Wikidata; Q93935415 |
Polymorphism and mutation databases | Progenetix; CVCL_VS68 |
Entry history | |
Entry creation | 25-Feb-2019 |
Last entry update | 29-Oct-2020 |
Version number | 5 |